Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Gilat Satellite Networks and Boeing have achieved a milestone to offer Gilat's multi-orbit Sidewinder electronically steered antenna as a future line-fit option for in-flight connectivity (IFC) service providers. This compact ESA will simplify installation, reduce maintenance costs, and enable earlier service entry, supporting advanced broadband co…
Zenas BioPharma announced that safety and efficacy results from the Phase 3 INDIGO trial evaluating its lead candidate Obexelimab for Immunoglobulin G4-Related Disease (IgG4-RD) will be presented at the EULAR 2026 Congress. The INDIGO trial met its primary and all four key secondary endpoints with high statistical significance, demonstrating a 56% …
A filing with the SEC revealed that HARROW, INC. director Adrienne L. Graves purchased 1,000 shares of common stock on May 18, 2026, for a total value of $31,070. This transaction occurred while the stock was trading near $30.90 and showing a decline year-to-date. Separately, the company recently reported first quarter financial results that fell b…
Antalpha Platform Holding Company announced robust Q1 2026 results with 52% year-over-year revenue growth and enhanced profitability driven by its scalable digital asset platform. The acquisition of Aurelion contributed significantly, boosting adjusted EBITDA margin to 64%. The company is advancing its tokenized gold strategy to generate yield and …
Natan Israeli, Chief Customer Officer at Kaltura Inc., executed a sale of common stock shares on May 15, 2026. The transaction was conducted under an established Rule 10b5-1 trading plan. This divestiture occurred against a backdrop of mixed financial news, as the company reported Q1 2026 earnings that saw revenue slightly exceed forecasts but were…
A director at Harrow, Inc. recently increased her personal stake in the company by purchasing 1,000 shares. This insider activity occurs against a backdrop of mixed financial news for the firm, which reported first-quarter results that missed analyst expectations. The transaction takes place while the stock is trading near the purchase price but re…
Societe Generale is maintaining an overweight recommendation for small-cap equities relative to large-caps nearly a year after making the call, pointing to monetary and PMI indicators, valuation differentials and earnings outlooks as supporting factors. The bank sees particular opportunity in the euro zone, while noting sector exposures and geopoli…
U.S. President Donald Trump called off planned strikes on Iran after Tehran routed a fresh peace proposal to Washington through Pakistan, saying there is a "very good chance" of reaching a deal to curb Iran's nuclear programme. The announcement eased some of the recent market tension: crude prices retreated slightly but Brent crude remained above $…
Cullinan Therapeutics announced that the FDA has granted Orphan Drug Designation to CLN-049, a novel FLT3xCD3 T cell engager under investigation for treating relapsed/refractory acute myeloid leukemia (AML). The designation supports the drug's potential to address significant unmet medical needs in AML, including in patients with poor prognosis due…
Garrett Motion Inc. announced its 2026 Technology and Investor Day scheduled for May 20, 2026, where it will present updates on its Turbo, Zero-Emission Vehicle, and Industrial technology portfolios, alongside its long-term growth strategies and financial priorities. The event will include real-time and replay webcast access.
Korro Bio announced the selection of KRRO-111, a proprietary GalNAc-conjugated oligonucleotide therapeutic, as a development candidate for treating Alpha-1 Antitrypsin Deficiency (AATD). KRRO-111 leverages the company's OPERA RNA editing platform to correct the pathogenic mutation in the SERPINA1 gene, achieving over 90% editing efficiency and sign…
Lexeo Therapeutics, a clinical-stage genetic medicine company focused on cardiovascular diseases, announced its participation in a fireside chat at the 2026 RBC Capital Markets Global Healthcare Conference. The live webcast will provide insights into their pipeline targeting genetic causes of heart conditions, featuring candidates like LX2006 and L…
Ambow Education Holding Ltd. (NYSE American: AMBO) has launched the HybriU Collaboration Board, an AI-powered phygital tool providing real-time collaborative whiteboard access via a single QR code. This innovation enables participants to interact with various content types without software installation or accounts, aiming to enhance hybrid collabor…
OKYO Pharma Limited appoints international expert Dr. Marta Sacchetti, MD, PhD, to its Scientific Advisory Board. This strategic addition strengthens the company's expertise in neuro-inflammatory corneal diseases, aligning with its development of urcosimod, a promising investigational therapy for neuropathic corneal pain (NCP). Having completed a s…
Osisko Development Corp. has appointed Greg Perrins as Vice President of Sustainable Development to enhance its approach to Indigenous relations and public sector engagement in British Columbia. Perrins brings over 15 years of experience in natural resource sectors and government roles, aiming to support the company’s flagship Cariboo Gold Project …
Tiziana Life Sciences Ltd. (Nasdaq: TLSA) announced updated positive clinical data from its ongoing Expanded Access Program evaluating intranasal foralumab in 14 patients with non-active Secondary Progressive Multiple Sclerosis (na-SPMS). The data showed intranasal foralumab was well tolerated with no new safety signals, demonstrated trends toward …
Quantum Cyber N.V. announced the filing of a provisional patent application with the USPTO for an autonomous naval mine countermeasure system designed to detect and neutralize underwater mines using unmanned aerial vehicles. The technology is timely and directly addresses a current military crisis in the Strait of Hormuz where Iran has deployed nav…
EyePoint, Inc., a clinical-stage biopharmaceutical company focused on innovative therapeutics for serious retinal diseases, announced its participation in several upcoming investor conferences including Stifel, Jefferies, and Goldman Sachs. The company highlighted its lead product candidate, DURAVYU™, a sustained delivery treatment undergoing Phase…
Orion Energy Systems announced preliminary unaudited results for fiscal year 2026, posting $86 million in revenue and adjusted EBITDA of at least $2 million, marking six consecutive quarters of positive adjusted EBITDA. The company reiterated fiscal year 2027 guidance with projected revenues between $95 million and $97 million and positive adjusted…
Tecnoglass, a leading producer of high-end aluminum and vinyl windows and architectural glass, announced attendance at three major investor conferences in May and June 2026. The company highlights its strong presence in the U.S. market, accounting for 95% of its revenues, and its significant manufacturing footprint in Colombia.
XORTX Therapeutics Inc., a clinical-stage pharmaceutical company specializing in therapies for gout and kidney diseases, has completed a $5 million public offering through issuing common shares and pre-funded warrants. The proceeds will support working capital, corporate purposes, and investor relations activities. The offering was made under an SE…
Vertex Inc. published a new global study highlighting growing revenue risks caused by misalignment among IT, Tax, and Finance teams in compliance processes. Despite strong ambitions for collaboration, many organizations suffer from governance gaps, poor data quality, and fragmented ownership, risking blocked transactions and delayed revenue. The re…
Fury Gold Mines Limited has initiated an extensive metallurgical testwork program at its 100% owned Eau Claire gold project in Quebec to support ongoing feasibility studies. The program aims to optimize ore processing, support tailings management, and ensure environmental compliance, paving the way for a detailed process flowsheet and development p…
UK-listed utility stocks slumped 7.5% on May 15 - their fourth-largest one-day fall since privatisation - while continental European peers dropped 2.8%. Analysts at UBS point to a rapid rise in gilt yields and renewed speculation about potential government intervention as the main drivers. The move hit regulated-asset-base (RAB) premia across netwo…
Bank of America’s May Global Fund Manager Survey found managers dramatically increasing equity exposure and reducing cash, driving valuation and positioning measures toward contrarian sell thresholds. Gains in profit expectations and heavy rotation into U.S. stocks, technology and commodities contrast with mounting inflation fears and growing expec…
